NABRIVA THERAPEUTICS PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0001 USD | 0.00% |
|
0.00% | +9,900.00% |
| 2023 | Nabriva Therapeutics plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 | CI |
| 2023 | Nabriva Therapeutics plc(OTCPK:NBRV.F) dropped from NASDAQ Composite Index | CI |
Quotes 5-day view
Delayed Quote OTC Markets| 2024-04-25 | |
|---|---|
| Last | 0.0001 $ |
| Volume | 1 358 |
| Change | +∞% |
| Opening | 0.00 |
| High | 0.00 |
| Low | 0.00 |
Performance
| 6 months | -99.98% | ||
| 1 year | -99.99% | ||
| 3 years | -100.00% | ||
| 5 years | -100.00% |
Volumes
marketsDaily volume
1 358
Estimated daily volume
1 358
Avg. Volume 20 sessions
1 361
Daily volume ratio
1.00
Avg. Volume 20 sessions USD
0.14
Record volume 1
5 619 564
Record volume 2
4 150 216
Record volume 3
2 476 893
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (USD)
323
Net sales (USD)
36 935 000
Number of employees
39
Sales / Employee (USD)
947 051
Free-Float
99.05 %
Free-Float capitalization (USD)
320
Average Daily Capital Traded
0.04%
Highs and lows
1 week
0.00
0.00
1 month
0.000.00
Current year
0.000.52
1 year
0.002.24
3 years
0.0058.00
5 years
0.00767.50
10 years
0.004 370.00
Indicators
Moving average 20 days
0.03
Moving average 50 days
0.01
Moving average 100 days
0.02
Price spread / (MMA20)
+26,200.00%
Price spread / (MMA50)
+10,500.00%
Price spread / (MMA100)
+15,900.00%
RSI 9 days
46.92
RSI 14 days
47.33
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| 0.00% | 0.00% | - | -99.99% | 323 | ||
| -0.06% | +0.81% | -2.31% | +16.66% | 103B | ||
| -0.84% | -1.52% | +0.56% | +10.15% | 95.28B | ||
| +0.90% | +3.56% | +1.69% | +0.17% | 22.15B | ||
| +0.58% | +0.46% | -17.37% | -23.66% | 21.02B | ||
| +2.04% | -2.57% | -9.30% | -29.69% | 18.15B | ||
| +3.17% | +1.71% | -41.01% | -36.44% | 16.73B | ||
| +3.38% | +18.58% | -14.85% | -39.76% | 16.05B | ||
| -1.28% | +3.02% | +3.21% | +34.59% | 13.68B | ||
| +1.08% | +11.37% | +33.54% | +4.89% | 12.17B | ||
| +1.98% | -1.93% | -24.71% | -34.07% | 8.24B | ||
| +7.91% | +17.17% | +299.30% | +248.71% | 8.19B | ||
| -0.75% | -3.05% | +7.90% | +94.25% | 7.76B | ||
| +0.95% | +0.62% | +0.17% | +46.25% | 7.71B | ||
| +5.81% | +6.81% | -54.46% | -70.98% | 7.17B | ||
| +0.72% | +5.24% | -1.21% | +29.51% | 6.99B | ||
| Average | +1.60% | +3.78% | +12.08% | +9.41% | ||
| Weighted average by Cap. | +0.59% | +1.87% | +2.09% | +9.54% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | +9,900.00% | ||
| 2023 | -100.00% | ||
| 2022 | -87.38% | ||
| 2021 | -75.25% | ||
| 2020 | -81.67% | ||
| 2019 | -9.59% | ||
| 2018 | -75.59% | ||
| 2017 | +0.34% | ||
| 2016 | -38.05% | ||
| 2015 | -27.34% |
- Stock Market
- Equities
- NBRVF Stock
- Quotes Nabriva Therapeutics plc
